nodes	percent_of_prediction	percent_of_DWPC	metapath
Azelastine—CYP2B6—Thiotepa—sarcoma	0.141	0.169	CbGbCtD
Azelastine—CYP1A1—Dacarbazine—sarcoma	0.103	0.123	CbGbCtD
Azelastine—CYP2E1—Dacarbazine—sarcoma	0.0795	0.0947	CbGbCtD
Azelastine—CYP2E1—Mitoxantrone—sarcoma	0.0617	0.0735	CbGbCtD
Azelastine—CYP1A2—Dacarbazine—sarcoma	0.046	0.0548	CbGbCtD
Azelastine—CYP3A4—Thiotepa—sarcoma	0.0434	0.0518	CbGbCtD
Azelastine—CYP2E1—Etoposide—sarcoma	0.0389	0.0463	CbGbCtD
Azelastine—ABCB1—Dactinomycin—sarcoma	0.0348	0.0415	CbGbCtD
Azelastine—CYP3A5—Vincristine—sarcoma	0.033	0.0393	CbGbCtD
Azelastine—ABCB1—Mitoxantrone—sarcoma	0.0312	0.0372	CbGbCtD
Azelastine—CYP3A5—Etoposide—sarcoma	0.0302	0.036	CbGbCtD
Azelastine—CYP2C8—Etoposide—sarcoma	0.029	0.0346	CbGbCtD
Azelastine—CYP2B6—Doxorubicin—sarcoma	0.0262	0.0312	CbGbCtD
Azelastine—CYP1A2—Etoposide—sarcoma	0.0225	0.0268	CbGbCtD
Azelastine—ABCB1—Vincristine—sarcoma	0.0215	0.0256	CbGbCtD
Azelastine—ABCB1—Etoposide—sarcoma	0.0197	0.0234	CbGbCtD
Azelastine—CYP3A4—Mitoxantrone—sarcoma	0.0187	0.0223	CbGbCtD
Azelastine—ABCB1—Doxorubicin—sarcoma	0.0134	0.016	CbGbCtD
Azelastine—CYP3A4—Vincristine—sarcoma	0.0129	0.0153	CbGbCtD
Azelastine—CYP2D6—Doxorubicin—sarcoma	0.0126	0.0151	CbGbCtD
Azelastine—CYP3A4—Etoposide—sarcoma	0.0118	0.014	CbGbCtD
Azelastine—CYP3A4—Doxorubicin—sarcoma	0.00803	0.00958	CbGbCtD
Azelastine—Malaise—Mitoxantrone—sarcoma	0.00047	0.00299	CcSEcCtD
Azelastine—Eye disorder—Etoposide—sarcoma	0.000465	0.00296	CcSEcCtD
Azelastine—Mouth ulceration—Doxorubicin—sarcoma	0.000465	0.00295	CcSEcCtD
Azelastine—Flushing—Etoposide—sarcoma	0.000462	0.00294	CcSEcCtD
Azelastine—Hypertension—Vincristine—sarcoma	0.000462	0.00293	CcSEcCtD
Azelastine—Myalgia—Vincristine—sarcoma	0.000455	0.00289	CcSEcCtD
Azelastine—Cough—Mitoxantrone—sarcoma	0.000454	0.00289	CcSEcCtD
Azelastine—Hypertension—Mitoxantrone—sarcoma	0.000449	0.00286	CcSEcCtD
Azelastine—Eczema—Epirubicin—sarcoma	0.000449	0.00285	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Thiotepa—sarcoma	0.000448	0.00285	CcSEcCtD
Azelastine—Abnormal vision—Doxorubicin—sarcoma	0.000448	0.00285	CcSEcCtD
Azelastine—Eye pain—Epirubicin—sarcoma	0.000447	0.00284	CcSEcCtD
Azelastine—Mental disability—Doxorubicin—sarcoma	0.000446	0.00284	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.000445	0.00283	CcSEcCtD
Azelastine—Myalgia—Mitoxantrone—sarcoma	0.000443	0.00282	CcSEcCtD
Azelastine—Chest pain—Mitoxantrone—sarcoma	0.000443	0.00282	CcSEcCtD
Azelastine—Paraesthesia—Thiotepa—sarcoma	0.000442	0.00281	CcSEcCtD
Azelastine—Anxiety—Mitoxantrone—sarcoma	0.000442	0.00281	CcSEcCtD
Azelastine—Discomfort—Mitoxantrone—sarcoma	0.000438	0.00278	CcSEcCtD
Azelastine—Somnolence—Thiotepa—sarcoma	0.000437	0.00278	CcSEcCtD
Azelastine—Anaphylactic shock—Vincristine—sarcoma	0.000436	0.00277	CcSEcCtD
Azelastine—Infection—Vincristine—sarcoma	0.000433	0.00276	CcSEcCtD
Azelastine—Increased appetite—Epirubicin—sarcoma	0.000429	0.00273	CcSEcCtD
Azelastine—Confusional state—Mitoxantrone—sarcoma	0.000428	0.00272	CcSEcCtD
Azelastine—Anaphylactic shock—Mitoxantrone—sarcoma	0.000425	0.0027	CcSEcCtD
Azelastine—Fatigue—Thiotepa—sarcoma	0.000424	0.0027	CcSEcCtD
Azelastine—Dysgeusia—Etoposide—sarcoma	0.000424	0.0027	CcSEcCtD
Azelastine—Infection—Mitoxantrone—sarcoma	0.000422	0.00268	CcSEcCtD
Azelastine—Fatigue—Dactinomycin—sarcoma	0.000421	0.00268	CcSEcCtD
Azelastine—Pain—Thiotepa—sarcoma	0.000421	0.00268	CcSEcCtD
Azelastine—Constipation—Thiotepa—sarcoma	0.000421	0.00268	CcSEcCtD
Azelastine—Back pain—Etoposide—sarcoma	0.000419	0.00266	CcSEcCtD
Azelastine—Pain—Dactinomycin—sarcoma	0.000418	0.00266	CcSEcCtD
Azelastine—Anaphylactoid reaction—Epirubicin—sarcoma	0.000416	0.00265	CcSEcCtD
Azelastine—Eczema—Doxorubicin—sarcoma	0.000415	0.00264	CcSEcCtD
Azelastine—Tachycardia—Mitoxantrone—sarcoma	0.000415	0.00264	CcSEcCtD
Azelastine—Eye pain—Doxorubicin—sarcoma	0.000413	0.00263	CcSEcCtD
Azelastine—Feeling abnormal—Thiotepa—sarcoma	0.000405	0.00258	CcSEcCtD
Azelastine—Feeling abnormal—Dactinomycin—sarcoma	0.000402	0.00256	CcSEcCtD
Azelastine—Gastrointestinal pain—Thiotepa—sarcoma	0.000402	0.00256	CcSEcCtD
Azelastine—Ill-defined disorder—Etoposide—sarcoma	0.000402	0.00255	CcSEcCtD
Azelastine—Gastrointestinal pain—Dactinomycin—sarcoma	0.000399	0.00254	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Vincristine—sarcoma	0.000398	0.00253	CcSEcCtD
Azelastine—Increased appetite—Doxorubicin—sarcoma	0.000397	0.00252	CcSEcCtD
Azelastine—Paraesthesia—Vincristine—sarcoma	0.000392	0.00249	CcSEcCtD
Azelastine—Malaise—Etoposide—sarcoma	0.000391	0.00248	CcSEcCtD
Azelastine—Face oedema—Epirubicin—sarcoma	0.000389	0.00247	CcSEcCtD
Azelastine—Vertigo—Etoposide—sarcoma	0.000389	0.00247	CcSEcCtD
Azelastine—Abdominal pain—Thiotepa—sarcoma	0.000389	0.00247	CcSEcCtD
Azelastine—Body temperature increased—Thiotepa—sarcoma	0.000389	0.00247	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000387	0.00246	CcSEcCtD
Azelastine—Abdominal pain—Dactinomycin—sarcoma	0.000386	0.00245	CcSEcCtD
Azelastine—Body temperature increased—Dactinomycin—sarcoma	0.000386	0.00245	CcSEcCtD
Azelastine—Anaphylactoid reaction—Doxorubicin—sarcoma	0.000385	0.00245	CcSEcCtD
Azelastine—Paraesthesia—Mitoxantrone—sarcoma	0.000382	0.00243	CcSEcCtD
Azelastine—Dyspnoea—Mitoxantrone—sarcoma	0.000379	0.00241	CcSEcCtD
Azelastine—Cough—Etoposide—sarcoma	0.000378	0.0024	CcSEcCtD
Azelastine—Somnolence—Mitoxantrone—sarcoma	0.000378	0.0024	CcSEcCtD
Azelastine—Fatigue—Vincristine—sarcoma	0.000376	0.00239	CcSEcCtD
Azelastine—Hypertension—Etoposide—sarcoma	0.000374	0.00238	CcSEcCtD
Azelastine—Constipation—Vincristine—sarcoma	0.000373	0.00237	CcSEcCtD
Azelastine—Pain—Vincristine—sarcoma	0.000373	0.00237	CcSEcCtD
Azelastine—Chest pain—Etoposide—sarcoma	0.000369	0.00234	CcSEcCtD
Azelastine—Fatigue—Mitoxantrone—sarcoma	0.000366	0.00233	CcSEcCtD
Azelastine—Discomfort—Etoposide—sarcoma	0.000364	0.00232	CcSEcCtD
Azelastine—Constipation—Mitoxantrone—sarcoma	0.000363	0.00231	CcSEcCtD
Azelastine—Pain—Mitoxantrone—sarcoma	0.000363	0.00231	CcSEcCtD
Azelastine—Hypersensitivity—Thiotepa—sarcoma	0.000363	0.0023	CcSEcCtD
Azelastine—Nasopharyngitis—Epirubicin—sarcoma	0.00036	0.00229	CcSEcCtD
Azelastine—Face oedema—Doxorubicin—sarcoma	0.00036	0.00229	CcSEcCtD
Azelastine—Hypersensitivity—Dactinomycin—sarcoma	0.00036	0.00229	CcSEcCtD
Azelastine—Gastrointestinal pain—Vincristine—sarcoma	0.000357	0.00227	CcSEcCtD
Azelastine—Confusional state—Etoposide—sarcoma	0.000356	0.00227	CcSEcCtD
Azelastine—Alanine aminotransferase increased—Epirubicin—sarcoma	0.000356	0.00226	CcSEcCtD
Azelastine—Anaphylactic shock—Etoposide—sarcoma	0.000353	0.00225	CcSEcCtD
Azelastine—Asthenia—Thiotepa—sarcoma	0.000353	0.00224	CcSEcCtD
Azelastine—Infection—Etoposide—sarcoma	0.000351	0.00223	CcSEcCtD
Azelastine—Asthenia—Dactinomycin—sarcoma	0.00035	0.00223	CcSEcCtD
Azelastine—Feeling abnormal—Mitoxantrone—sarcoma	0.00035	0.00223	CcSEcCtD
Azelastine—Asthma—Epirubicin—sarcoma	0.000348	0.00222	CcSEcCtD
Azelastine—Pruritus—Thiotepa—sarcoma	0.000348	0.00221	CcSEcCtD
Azelastine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000347	0.00221	CcSEcCtD
Azelastine—Tachycardia—Etoposide—sarcoma	0.000345	0.00219	CcSEcCtD
Azelastine—Abdominal pain—Vincristine—sarcoma	0.000345	0.00219	CcSEcCtD
Azelastine—Body temperature increased—Vincristine—sarcoma	0.000345	0.00219	CcSEcCtD
Azelastine—Diarrhoea—Thiotepa—sarcoma	0.000337	0.00214	CcSEcCtD
Azelastine—Abdominal pain—Mitoxantrone—sarcoma	0.000336	0.00214	CcSEcCtD
Azelastine—Body temperature increased—Mitoxantrone—sarcoma	0.000336	0.00214	CcSEcCtD
Azelastine—Bronchitis—Epirubicin—sarcoma	0.000335	0.00213	CcSEcCtD
Azelastine—Diarrhoea—Dactinomycin—sarcoma	0.000334	0.00212	CcSEcCtD
Azelastine—Nasopharyngitis—Doxorubicin—sarcoma	0.000334	0.00212	CcSEcCtD
Azelastine—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.000329	0.00209	CcSEcCtD
Azelastine—Dizziness—Thiotepa—sarcoma	0.000325	0.00207	CcSEcCtD
Azelastine—Upper respiratory tract infection—Epirubicin—sarcoma	0.000324	0.00206	CcSEcCtD
Azelastine—Asthma—Doxorubicin—sarcoma	0.000322	0.00205	CcSEcCtD
Azelastine—Pollakiuria—Epirubicin—sarcoma	0.000322	0.00205	CcSEcCtD
Azelastine—Hypersensitivity—Vincristine—sarcoma	0.000321	0.00204	CcSEcCtD
Azelastine—Paraesthesia—Etoposide—sarcoma	0.000317	0.00202	CcSEcCtD
Azelastine—Weight increased—Epirubicin—sarcoma	0.000317	0.00202	CcSEcCtD
Azelastine—Dyspnoea—Etoposide—sarcoma	0.000315	0.002	CcSEcCtD
Azelastine—Somnolence—Etoposide—sarcoma	0.000314	0.002	CcSEcCtD
Azelastine—Hypersensitivity—Mitoxantrone—sarcoma	0.000313	0.00199	CcSEcCtD
Azelastine—Asthenia—Vincristine—sarcoma	0.000313	0.00199	CcSEcCtD
Azelastine—Vomiting—Thiotepa—sarcoma	0.000313	0.00199	CcSEcCtD
Azelastine—Vomiting—Dactinomycin—sarcoma	0.00031	0.00197	CcSEcCtD
Azelastine—Rash—Thiotepa—sarcoma	0.00031	0.00197	CcSEcCtD
Azelastine—Bronchitis—Doxorubicin—sarcoma	0.00031	0.00197	CcSEcCtD
Azelastine—Dermatitis—Thiotepa—sarcoma	0.00031	0.00197	CcSEcCtD
Azelastine—Headache—Thiotepa—sarcoma	0.000308	0.00196	CcSEcCtD
Azelastine—Rash—Dactinomycin—sarcoma	0.000308	0.00196	CcSEcCtD
Azelastine—Asthenia—Mitoxantrone—sarcoma	0.000305	0.00194	CcSEcCtD
Azelastine—Fatigue—Etoposide—sarcoma	0.000305	0.00194	CcSEcCtD
Azelastine—Pain—Etoposide—sarcoma	0.000302	0.00192	CcSEcCtD
Azelastine—Constipation—Etoposide—sarcoma	0.000302	0.00192	CcSEcCtD
Azelastine—Conjunctivitis—Epirubicin—sarcoma	0.000302	0.00192	CcSEcCtD
Azelastine—Upper respiratory tract infection—Doxorubicin—sarcoma	0.0003	0.0019	CcSEcCtD
Azelastine—Diarrhoea—Vincristine—sarcoma	0.000299	0.0019	CcSEcCtD
Azelastine—Pollakiuria—Doxorubicin—sarcoma	0.000298	0.00189	CcSEcCtD
Azelastine—HRH3—hematopoietic system—sarcoma	0.000298	0.0811	CbGeAlD
Azelastine—Haematuria—Epirubicin—sarcoma	0.000296	0.00188	CcSEcCtD
Azelastine—Weight increased—Doxorubicin—sarcoma	0.000293	0.00187	CcSEcCtD
Azelastine—Epistaxis—Epirubicin—sarcoma	0.000293	0.00186	CcSEcCtD
Azelastine—Nausea—Thiotepa—sarcoma	0.000292	0.00186	CcSEcCtD
Azelastine—Sinusitis—Epirubicin—sarcoma	0.000291	0.00185	CcSEcCtD
Azelastine—Feeling abnormal—Etoposide—sarcoma	0.000291	0.00185	CcSEcCtD
Azelastine—Diarrhoea—Mitoxantrone—sarcoma	0.000291	0.00185	CcSEcCtD
Azelastine—Nausea—Dactinomycin—sarcoma	0.00029	0.00184	CcSEcCtD
Azelastine—Gastrointestinal pain—Etoposide—sarcoma	0.000289	0.00184	CcSEcCtD
Azelastine—Dizziness—Vincristine—sarcoma	0.000289	0.00183	CcSEcCtD
Azelastine—Rhinitis—Epirubicin—sarcoma	0.00028	0.00178	CcSEcCtD
Azelastine—Body temperature increased—Etoposide—sarcoma	0.000279	0.00178	CcSEcCtD
Azelastine—Abdominal pain—Etoposide—sarcoma	0.000279	0.00178	CcSEcCtD
Azelastine—Conjunctivitis—Doxorubicin—sarcoma	0.000279	0.00178	CcSEcCtD
Azelastine—Hypoaesthesia—Epirubicin—sarcoma	0.000277	0.00176	CcSEcCtD
Azelastine—Vomiting—Vincristine—sarcoma	0.000277	0.00176	CcSEcCtD
Azelastine—Pharyngitis—Epirubicin—sarcoma	0.000277	0.00176	CcSEcCtD
Azelastine—Rash—Vincristine—sarcoma	0.000275	0.00175	CcSEcCtD
Azelastine—Dermatitis—Vincristine—sarcoma	0.000275	0.00175	CcSEcCtD
Azelastine—Haematuria—Doxorubicin—sarcoma	0.000274	0.00174	CcSEcCtD
Azelastine—Headache—Vincristine—sarcoma	0.000273	0.00174	CcSEcCtD
Azelastine—Epistaxis—Doxorubicin—sarcoma	0.000271	0.00172	CcSEcCtD
Azelastine—Vomiting—Mitoxantrone—sarcoma	0.00027	0.00172	CcSEcCtD
Azelastine—Sinusitis—Doxorubicin—sarcoma	0.00027	0.00171	CcSEcCtD
Azelastine—Visual impairment—Epirubicin—sarcoma	0.000269	0.00171	CcSEcCtD
Azelastine—Rash—Mitoxantrone—sarcoma	0.000268	0.0017	CcSEcCtD
Azelastine—Dermatitis—Mitoxantrone—sarcoma	0.000268	0.0017	CcSEcCtD
Azelastine—Headache—Mitoxantrone—sarcoma	0.000266	0.00169	CcSEcCtD
Azelastine—Eye disorder—Epirubicin—sarcoma	0.000261	0.00166	CcSEcCtD
Azelastine—Hypersensitivity—Etoposide—sarcoma	0.00026	0.00166	CcSEcCtD
Azelastine—Nausea—Vincristine—sarcoma	0.000259	0.00165	CcSEcCtD
Azelastine—Flushing—Epirubicin—sarcoma	0.000259	0.00165	CcSEcCtD
Azelastine—Rhinitis—Doxorubicin—sarcoma	0.000259	0.00164	CcSEcCtD
Azelastine—Hypoaesthesia—Doxorubicin—sarcoma	0.000257	0.00163	CcSEcCtD
Azelastine—Pharyngitis—Doxorubicin—sarcoma	0.000256	0.00163	CcSEcCtD
Azelastine—Asthenia—Etoposide—sarcoma	0.000254	0.00161	CcSEcCtD
Azelastine—Nausea—Mitoxantrone—sarcoma	0.000252	0.0016	CcSEcCtD
Azelastine—Pruritus—Etoposide—sarcoma	0.00025	0.00159	CcSEcCtD
Azelastine—Visual impairment—Doxorubicin—sarcoma	0.000249	0.00158	CcSEcCtD
Azelastine—Diarrhoea—Etoposide—sarcoma	0.000242	0.00154	CcSEcCtD
Azelastine—Eye disorder—Doxorubicin—sarcoma	0.000241	0.00153	CcSEcCtD
Azelastine—Flushing—Doxorubicin—sarcoma	0.000239	0.00152	CcSEcCtD
Azelastine—Tension—Epirubicin—sarcoma	0.000238	0.00151	CcSEcCtD
Azelastine—Dysgeusia—Epirubicin—sarcoma	0.000238	0.00151	CcSEcCtD
Azelastine—Nervousness—Epirubicin—sarcoma	0.000236	0.0015	CcSEcCtD
Azelastine—Back pain—Epirubicin—sarcoma	0.000235	0.00149	CcSEcCtD
Azelastine—Dizziness—Etoposide—sarcoma	0.000234	0.00149	CcSEcCtD
Azelastine—Vision blurred—Epirubicin—sarcoma	0.000229	0.00145	CcSEcCtD
Azelastine—Ill-defined disorder—Epirubicin—sarcoma	0.000225	0.00143	CcSEcCtD
Azelastine—Vomiting—Etoposide—sarcoma	0.000225	0.00143	CcSEcCtD
Azelastine—Agitation—Epirubicin—sarcoma	0.000223	0.00142	CcSEcCtD
Azelastine—Rash—Etoposide—sarcoma	0.000223	0.00142	CcSEcCtD
Azelastine—Dermatitis—Etoposide—sarcoma	0.000223	0.00142	CcSEcCtD
Azelastine—Headache—Etoposide—sarcoma	0.000221	0.00141	CcSEcCtD
Azelastine—Tension—Doxorubicin—sarcoma	0.00022	0.0014	CcSEcCtD
Azelastine—Dysgeusia—Doxorubicin—sarcoma	0.00022	0.0014	CcSEcCtD
Azelastine—Malaise—Epirubicin—sarcoma	0.000219	0.00139	CcSEcCtD
Azelastine—Nervousness—Doxorubicin—sarcoma	0.000218	0.00139	CcSEcCtD
Azelastine—Vertigo—Epirubicin—sarcoma	0.000218	0.00139	CcSEcCtD
Azelastine—Back pain—Doxorubicin—sarcoma	0.000217	0.00138	CcSEcCtD
Azelastine—Palpitations—Epirubicin—sarcoma	0.000215	0.00136	CcSEcCtD
Azelastine—Cough—Epirubicin—sarcoma	0.000212	0.00135	CcSEcCtD
Azelastine—Vision blurred—Doxorubicin—sarcoma	0.000212	0.00135	CcSEcCtD
Azelastine—Nausea—Etoposide—sarcoma	0.00021	0.00133	CcSEcCtD
Azelastine—Hypertension—Epirubicin—sarcoma	0.00021	0.00133	CcSEcCtD
Azelastine—Ill-defined disorder—Doxorubicin—sarcoma	0.000208	0.00133	CcSEcCtD
Azelastine—Chest pain—Epirubicin—sarcoma	0.000207	0.00131	CcSEcCtD
Azelastine—Myalgia—Epirubicin—sarcoma	0.000207	0.00131	CcSEcCtD
Azelastine—Agitation—Doxorubicin—sarcoma	0.000206	0.00131	CcSEcCtD
Azelastine—Anxiety—Epirubicin—sarcoma	0.000206	0.00131	CcSEcCtD
Azelastine—Discomfort—Epirubicin—sarcoma	0.000204	0.0013	CcSEcCtD
Azelastine—Malaise—Doxorubicin—sarcoma	0.000203	0.00129	CcSEcCtD
Azelastine—Dry mouth—Epirubicin—sarcoma	0.000202	0.00129	CcSEcCtD
Azelastine—Vertigo—Doxorubicin—sarcoma	0.000202	0.00128	CcSEcCtD
Azelastine—Confusional state—Epirubicin—sarcoma	0.0002	0.00127	CcSEcCtD
Azelastine—Palpitations—Doxorubicin—sarcoma	0.000198	0.00126	CcSEcCtD
Azelastine—Anaphylactic shock—Epirubicin—sarcoma	0.000198	0.00126	CcSEcCtD
Azelastine—Infection—Epirubicin—sarcoma	0.000197	0.00125	CcSEcCtD
Azelastine—Cough—Doxorubicin—sarcoma	0.000196	0.00125	CcSEcCtD
Azelastine—Hypertension—Doxorubicin—sarcoma	0.000194	0.00123	CcSEcCtD
Azelastine—Tachycardia—Epirubicin—sarcoma	0.000193	0.00123	CcSEcCtD
Azelastine—Chest pain—Doxorubicin—sarcoma	0.000191	0.00122	CcSEcCtD
Azelastine—Myalgia—Doxorubicin—sarcoma	0.000191	0.00122	CcSEcCtD
Azelastine—Anxiety—Doxorubicin—sarcoma	0.000191	0.00121	CcSEcCtD
Azelastine—Discomfort—Doxorubicin—sarcoma	0.000189	0.0012	CcSEcCtD
Azelastine—Dry mouth—Doxorubicin—sarcoma	0.000187	0.00119	CcSEcCtD
Azelastine—Confusional state—Doxorubicin—sarcoma	0.000185	0.00118	CcSEcCtD
Azelastine—Anaphylactic shock—Doxorubicin—sarcoma	0.000183	0.00117	CcSEcCtD
Azelastine—Infection—Doxorubicin—sarcoma	0.000182	0.00116	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000181	0.00115	CcSEcCtD
Azelastine—Tachycardia—Doxorubicin—sarcoma	0.000179	0.00114	CcSEcCtD
Azelastine—Paraesthesia—Epirubicin—sarcoma	0.000178	0.00113	CcSEcCtD
Azelastine—Dyspnoea—Epirubicin—sarcoma	0.000177	0.00112	CcSEcCtD
Azelastine—Somnolence—Epirubicin—sarcoma	0.000176	0.00112	CcSEcCtD
Azelastine—Fatigue—Epirubicin—sarcoma	0.000171	0.00109	CcSEcCtD
Azelastine—Pain—Epirubicin—sarcoma	0.000169	0.00108	CcSEcCtD
Azelastine—Constipation—Epirubicin—sarcoma	0.000169	0.00108	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000167	0.00106	CcSEcCtD
Azelastine—Paraesthesia—Doxorubicin—sarcoma	0.000165	0.00105	CcSEcCtD
Azelastine—Dyspnoea—Doxorubicin—sarcoma	0.000163	0.00104	CcSEcCtD
Azelastine—Feeling abnormal—Epirubicin—sarcoma	0.000163	0.00104	CcSEcCtD
Azelastine—Somnolence—Doxorubicin—sarcoma	0.000163	0.00104	CcSEcCtD
Azelastine—Gastrointestinal pain—Epirubicin—sarcoma	0.000162	0.00103	CcSEcCtD
Azelastine—Fatigue—Doxorubicin—sarcoma	0.000158	0.001	CcSEcCtD
Azelastine—Pain—Doxorubicin—sarcoma	0.000157	0.000997	CcSEcCtD
Azelastine—Constipation—Doxorubicin—sarcoma	0.000157	0.000997	CcSEcCtD
Azelastine—Abdominal pain—Epirubicin—sarcoma	0.000157	0.000996	CcSEcCtD
Azelastine—Body temperature increased—Epirubicin—sarcoma	0.000157	0.000996	CcSEcCtD
Azelastine—Feeling abnormal—Doxorubicin—sarcoma	0.000151	0.000961	CcSEcCtD
Azelastine—Gastrointestinal pain—Doxorubicin—sarcoma	0.00015	0.000953	CcSEcCtD
Azelastine—CYP2A6—seminal vesicle—sarcoma	0.000148	0.0402	CbGeAlD
Azelastine—Hypersensitivity—Epirubicin—sarcoma	0.000146	0.000928	CcSEcCtD
Azelastine—Abdominal pain—Doxorubicin—sarcoma	0.000145	0.000921	CcSEcCtD
Azelastine—Body temperature increased—Doxorubicin—sarcoma	0.000145	0.000921	CcSEcCtD
Azelastine—Asthenia—Epirubicin—sarcoma	0.000142	0.000904	CcSEcCtD
Azelastine—Pruritus—Epirubicin—sarcoma	0.00014	0.000891	CcSEcCtD
Azelastine—Diarrhoea—Epirubicin—sarcoma	0.000136	0.000862	CcSEcCtD
Azelastine—Hypersensitivity—Doxorubicin—sarcoma	0.000135	0.000859	CcSEcCtD
Azelastine—Asthenia—Doxorubicin—sarcoma	0.000132	0.000836	CcSEcCtD
Azelastine—Dizziness—Epirubicin—sarcoma	0.000131	0.000833	CcSEcCtD
Azelastine—Pruritus—Doxorubicin—sarcoma	0.00013	0.000825	CcSEcCtD
Azelastine—CYP2C8—mammary gland—sarcoma	0.000129	0.0352	CbGeAlD
Azelastine—Vomiting—Epirubicin—sarcoma	0.000126	0.000801	CcSEcCtD
Azelastine—Diarrhoea—Doxorubicin—sarcoma	0.000125	0.000798	CcSEcCtD
Azelastine—Rash—Epirubicin—sarcoma	0.000125	0.000794	CcSEcCtD
Azelastine—Dermatitis—Epirubicin—sarcoma	0.000125	0.000794	CcSEcCtD
Azelastine—Headache—Epirubicin—sarcoma	0.000124	0.000789	CcSEcCtD
Azelastine—Dizziness—Doxorubicin—sarcoma	0.000121	0.000771	CcSEcCtD
Azelastine—Nausea—Epirubicin—sarcoma	0.000118	0.000748	CcSEcCtD
Azelastine—Vomiting—Doxorubicin—sarcoma	0.000117	0.000741	CcSEcCtD
Azelastine—Rash—Doxorubicin—sarcoma	0.000116	0.000735	CcSEcCtD
Azelastine—Dermatitis—Doxorubicin—sarcoma	0.000115	0.000734	CcSEcCtD
Azelastine—Headache—Doxorubicin—sarcoma	0.000115	0.00073	CcSEcCtD
Azelastine—CYP2C9—mammary gland—sarcoma	0.000115	0.0313	CbGeAlD
Azelastine—Nausea—Doxorubicin—sarcoma	0.000109	0.000692	CcSEcCtD
Azelastine—KCNH2—myometrium—sarcoma	0.0001	0.0273	CbGeAlD
Azelastine—KCNH2—seminal vesicle—sarcoma	9.05e-05	0.0247	CbGeAlD
Azelastine—CYP2C19—hematopoietic system—sarcoma	9.02e-05	0.0246	CbGeAlD
Azelastine—KCNH2—hematopoietic system—sarcoma	8.6e-05	0.0234	CbGeAlD
Azelastine—HRH1—myometrium—sarcoma	8.03e-05	0.0219	CbGeAlD
Azelastine—CYP2C8—hematopoietic system—sarcoma	7.87e-05	0.0214	CbGeAlD
Azelastine—CYP1A2—hematopoietic system—sarcoma	7.37e-05	0.0201	CbGeAlD
Azelastine—CYP1A1—hematopoietic system—sarcoma	7.27e-05	0.0198	CbGeAlD
Azelastine—CYP2A6—liver—sarcoma	7.26e-05	0.0198	CbGeAlD
Azelastine—CYP3A5—hematopoietic system—sarcoma	7.1e-05	0.0193	CbGeAlD
Azelastine—CYP2B6—hematopoietic system—sarcoma	7.06e-05	0.0192	CbGeAlD
Azelastine—CYP2C9—hematopoietic system—sarcoma	6.99e-05	0.019	CbGeAlD
Azelastine—CYP2E1—seminal vesicle—sarcoma	6.97e-05	0.019	CbGeAlD
Azelastine—HRH1—hematopoietic system—sarcoma	6.9e-05	0.0188	CbGeAlD
Azelastine—HRH1—connective tissue—sarcoma	6.64e-05	0.0181	CbGeAlD
Azelastine—CYP2E1—hematopoietic system—sarcoma	6.63e-05	0.018	CbGeAlD
Azelastine—KCNH2—cardiac atrium—sarcoma	6.53e-05	0.0178	CbGeAlD
Azelastine—KCNH2—uterus—sarcoma	6.5e-05	0.0177	CbGeAlD
Azelastine—CYP1A1—skin of body—sarcoma	6.32e-05	0.0172	CbGeAlD
Azelastine—CYP2B6—skin of body—sarcoma	6.14e-05	0.0167	CbGeAlD
Azelastine—HRH1—smooth muscle tissue—sarcoma	6.07e-05	0.0165	CbGeAlD
Azelastine—CYP1A1—cardiac atrium—sarcoma	5.52e-05	0.015	CbGeAlD
Azelastine—KCNH2—bone marrow—sarcoma	5.51e-05	0.015	CbGeAlD
Azelastine—CYP1A1—uterus—sarcoma	5.49e-05	0.0149	CbGeAlD
Azelastine—CYP3A4—hematopoietic system—sarcoma	5.33e-05	0.0145	CbGeAlD
Azelastine—CYP2D6—hematopoietic system—sarcoma	5.25e-05	0.0143	CbGeAlD
Azelastine—CYP2B6—lymphoid tissue—sarcoma	4.97e-05	0.0135	CbGeAlD
Azelastine—KCNH2—testis—sarcoma	4.71e-05	0.0128	CbGeAlD
Azelastine—CYP2C19—liver—sarcoma	4.67e-05	0.0127	CbGeAlD
Azelastine—CYP2E1—lymphoid tissue—sarcoma	4.66e-05	0.0127	CbGeAlD
Azelastine—HRH1—tendon—sarcoma	4.56e-05	0.0124	CbGeAlD
Azelastine—ABCB1—myometrium—sarcoma	4.39e-05	0.012	CbGeAlD
Azelastine—CYP2E1—tendon—sarcoma	4.39e-05	0.0119	CbGeAlD
Azelastine—CYP2C8—testis—sarcoma	4.31e-05	0.0117	CbGeAlD
Azelastine—ABCB1—embryo—sarcoma	4.23e-05	0.0115	CbGeAlD
Azelastine—CYP2C8—liver—sarcoma	4.08e-05	0.0111	CbGeAlD
Azelastine—ABCB1—seminal vesicle—sarcoma	3.97e-05	0.0108	CbGeAlD
Azelastine—CYP2B6—testis—sarcoma	3.87e-05	0.0105	CbGeAlD
Azelastine—CYP1A2—liver—sarcoma	3.82e-05	0.0104	CbGeAlD
Azelastine—HRH1—testis—sarcoma	3.78e-05	0.0103	CbGeAlD
Azelastine—ABCB1—hematopoietic system—sarcoma	3.77e-05	0.0103	CbGeAlD
Azelastine—CYP1A1—liver—sarcoma	3.76e-05	0.0103	CbGeAlD
Azelastine—CYP3A5—liver—sarcoma	3.68e-05	0.01	CbGeAlD
Azelastine—CYP2B6—liver—sarcoma	3.66e-05	0.00996	CbGeAlD
Azelastine—CYP2E1—testis—sarcoma	3.63e-05	0.00989	CbGeAlD
Azelastine—CYP2C9—liver—sarcoma	3.62e-05	0.00987	CbGeAlD
Azelastine—CYP2E1—liver—sarcoma	3.43e-05	0.00935	CbGeAlD
Azelastine—KCNH2—lymph node—sarcoma	3.42e-05	0.00931	CbGeAlD
Azelastine—CYP1A1—lymph node—sarcoma	2.89e-05	0.00786	CbGeAlD
Azelastine—CYP2D6—testis—sarcoma	2.87e-05	0.00783	CbGeAlD
Azelastine—ABCB1—uterus—sarcoma	2.85e-05	0.00776	CbGeAlD
Azelastine—CYP3A4—liver—sarcoma	2.76e-05	0.00752	CbGeAlD
Azelastine—HRH1—lymph node—sarcoma	2.74e-05	0.00746	CbGeAlD
Azelastine—CYP2D6—liver—sarcoma	2.72e-05	0.0074	CbGeAlD
Azelastine—ABCB1—lymphoid tissue—sarcoma	2.66e-05	0.00724	CbGeAlD
Azelastine—ABCB1—bone marrow—sarcoma	2.42e-05	0.00659	CbGeAlD
Azelastine—ABCB1—testis—sarcoma	2.07e-05	0.00563	CbGeAlD
Azelastine—ABCB1—liver—sarcoma	1.96e-05	0.00533	CbGeAlD
Azelastine—ABCB1—lymph node—sarcoma	1.5e-05	0.00408	CbGeAlD
